SCHEMBL21961848

SCHEMBL21961848

C=C[C@H]1CCC[C@H](OC)C1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
ALDH1A1 P00352 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678624 0.80 DPP4 (0.33) DPP4DPP7
SCHEMBL910644 0.78 DPP4 (0.36) DPP4DPP7
SCHEMBL28244513 0.78 DPP4 (0.33) DPP4DPP7
SCHEMBL24435063 0.77 DPP4 (0.32) DPP4DPP7
SCHEMBL19401359 0.77 DPP4 (0.32) DPP4DPP7
SCHEMBL14270060 0.75 DPP4 (0.40) DPP4DPP7
SCHEMBL7984091 0.75 ALDH1A1 (0.36) ALDH1A1ALOX15
SCHEMBL7990091 0.75 ALDH1A1 (0.36) ALDH1A1ALOX15
SCHEMBL7990097 0.75 ALDH1A1 (0.36) ALDH1A1ALOX15
SCHEMBL5482843 0.75 DPP4 (0.40) DPP4DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131201-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131201-A1 TYK2 INHIBITORS AND USES THEREOF TYK2, JAK2, JAK1 DPP4 3765/4885DPP7 2864/4885ALDH1A1 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.